About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5613583
Allelic
Composition
Gt(ROSA)26Sortm4(Wnt7b)Flng/Gt(ROSA)26Sor+
Rptortm1Rueg/Rptor+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * CD-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm4(Wnt7b)Flng mutation (0 available); any Gt(ROSA)26Sor mutation (1098 available)
Rptortm1Rueg mutation (1 available); any Rptor mutation (115 available)
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• when cre expression is suppressed by doxycycline treatment until 1 month of age the marrow cavity is decreased
• when cre expression is suppressed by doxycycline treatment until 1 month of age mice show very high bone mass 3 weeks after stopping doxycycline treatment


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/25/2025
MGI 6.24
The Jackson Laboratory